DeviceTalks Podcast Network

In this episode of IntuitiveTalks, Host Tom Salemi visits Intuitive’s Atlanta hub to sit down with Brian Miller, executive vice president and chief digital officer. Miller, who witnessed the first telesurgery procedure in 2001, shares his perspective on how surgical robotics has advanced beyond many early barriers to long-distance surgery. He emphasizes that adoption must be driven by user needs, not hype, with success hinging on meeting the daily realities of surgeons, patients, and health systems. This practical, patient-centered conversation explores what’s next for telesurgery. This conversation comes to you courtesy of Blue Goat Cyber. To learn more, visit: https://bluegoatcyber.com/ *** Enjoy this podcast? Follow the DeviceTalks Podcast Network, home of IntuitiveTalks, on all major podcast players: https://devicetalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an future episode.

In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown talks with Jyoti Gera, CEO of CardioVascular and Interventional Solutions for GE HealthCare, about her journey into the MedTech industry, the significance of cardiovascular health, the challenges faced in patient care, and the innovative solutions GE HealthCare is implementing to improve outcomes. Jyoti emphasizes the role of artificial intelligence in enhancing early detection and personalizing treatment, while also outlining the future of cardiology care as more connected and efficient. The conversation highlights the importance of collaboration in the healthcare ecosystem to address the growing burden of cardiovascular disease. This week’s FOMO guest Chris Steadham, vice president of technology at Aptyx, unpacks the evolution of implants and delivery systems. He emphasizes the importance of co-developing delivery systems alongside implants to ensure optimal performance and physician satisfaction. The discussion also touches on the impact of emerging technologies like AI and robotics in reshaping interventional procedures. For more information, go to https://aptyx.com/ Paul Grand, CEO of MedTech Innovator, commandeers the Newmarker’s Newsmakers to reveal the Finalists for MedTech Innovator’s finalists for its early-stage and execution awards. Read them here at MassDevice.https://www.massdevice.com/medtech-innovator-names-2025-grand-prize-finalists/ Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:04) - Keynote Interview with Jyoti Gera, CEO, CardioVascular & Interventional Solutions, GE HealthCare(00:02:45) - Welcome Paul Grand of MedTech Innovator(00:05:15) - MTI’s Execution Award Finalists(00:16:15) - MTI’s Early-stage Award Finalists(00:35:05) - FOMO with Chris Steadham, vice president, technology, Aptyx

In this episode of DeviceTalks Weekly, CMR Surgical CEO Massimiliano Colella joins Editorial Director Tom Salemi to share his wide-ranging journey through the MedTech industry. He talks about his experiences across global markets, his move from MedTech into the provider world, and why partnerships are critical to healthcare. Colella also dives into the future of surgical robotics, the importance of digital transformation, and CMR’s strategic vision moving forward. Sticking with the surgical robotics theme, our FOMO guest this week is Maggie Nixon, CEO of Capstan Medical, who sits down with Managing Editor Kayleen Brown. A big thanks to Vantedge Medical for sponsoring this episode of DeviceTalks Weekly. Learn more at https://vantedgemedical.com/ Be sure to catch Kayleen’s two-part interview with Cassandra Haupers, Director of Global Business Development, Machining at Vantedge Medical. (Want even more? Revisit their DeviceTalks West session from last year go to: https://event.on24.com/wcc/r/4612496/CCDA4762BD61D414E6C0DBC1D002216D?partnerref=DTWeekly .) Stick around for MassDevice’s Chris Newmarker’s Newsmakers listed in the timeline below. Thanks for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Episode rundown: 2:11 – Tom’s beef with Minnesota6:06 – Smith+Nephew reports positive clinical evidence for bioinductive implant8:39 – Dexcom CEO takes temporary leave of absence10:27 – Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project13:24 – Siemens Healthineers, Stryker partner on neurovascular robotics17:31 – Medtech Big 100: The world’s largest medical device companies23:00 – [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical25:00 – FOMO – Maggie Nixon, Capstan Medical36:41 – Keynote – Massimiliano Colella, CMR Surgical55:58 – [Part 2] Cassandra Haupers, Vantedge Medical Chapters (00:02:11) - Tom’s beef with Minnesota(00:06:06) - Smith+Nephew reports positive clinical evidence for bioinductive implant(00:08:39) - Dexcom CEO takes temporary leave of absence(00:10:27) - Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project(00:13:24) - Siemens Healthineers, Stryker partner on neurovascular robotics(00:17:31) - Medtech Big 100: The world’s largest medical device companies(00:23:00) - [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical(00:25:00) - FOMO – Maggie Nixon, Capstan Medical(00:36:41) - Keynote – Massimiliano Colella, CMR Surgical(00:55:58) - [Part 2] Cassandra Haupers, Vantedge Medical

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Santosh Prabhu, PhD, Divisional Vice President of Product Development for Abbott’s Structural Heart business, to discuss the company’s expanding portfolio and its impact on patients. Prabhu outlines Abbott’s transcatheter solutions, including MitraClip, TriClip, and Navitor, and shares updates on next-generation mitral and tricuspid valve replacement programs. He highlights how imaging advancements, new materials, and design innovations are enabling minimally invasive therapies for patients who are not candidates for surgery. The conversation also touches on Abbott’s HeartMates program, which connects and supports patients and families as they navigate cardiovascular conditions. Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/. Thank you for listening to AbbottTalks! *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/. Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, Host Tom Salemi and managing editor Kayleen Brown recap their recent West Coast tour—including a stop at the Santa Clara Convention Center, home of DeviceTalks West on Oct. 15–16. Register at West.DeviceTalks.com. They also share highlights from the MedtechVISION conference, including Kayleen’s brush with greatness—the winner of the Ferolyn Powell Award. This week’s FOMO segment features Medtronic’s Julie Cole, who updates listeners on the latest challenges and opportunities in the ASC sector in a conversation with DeviceTalks producer Emira Wininger. In the keynote interview, Tom sits down with Bioretec’s new CEO, Sarah van Hellenberg Hubar-Fisher, to talk about her career in MedTech and her decision to lead the company’s mission to transform orthopedic healing with advanced materials and bioabsorbable implants. Thanks for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:30) - MedtechVISION and the Ferolyn Powell award(00:06:38) - the Ferolyn Powell award winner(00:09:00) - Exciting Updates and Keynotes at DeviceTalks West Conference(00:12:55) - Connected Health DeviceTalks Tuesdays series(00:15:18) - FOMO – Medtronic’s Julie Cole on the Future of ASCs and MedTech Innovation(00:25:40) - Keynote Interview - Sarah Hubar-Fisher, CEO of Bioretec(00:32:28) - Challenges and Triumphs in MedTech Regulatory and Market Adoption(00:35:37) - Hubar-Fisher’s Journey from Corporate to Venture Capital and BioRetech(00:41:40) - BioRetech's Innovative Magnesium Alloy Implants for Orthopedic Solutions(00:49:06) - Bioretech's Journey to Market Leadership in Bioabsorbable Implants

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Valeska Schroeder, CEO of Cerapedics, about her company’s success in developing drug-device combination products aimed at enhancing bone repair in spinal fusion surgeries. In this week’s FOMO session, Managing Editor Kayleen Brown explores the prospects of smart catheters with insights from Asheesh Divetia, head of engineering and technology at Cirtec Medical. For more information, go to cirtecmed.com. Later, MassDevice Editor Chris Newmarker brings this week’s Newsmakers - GE Healthcare, Edwards Lifesciences, Vectorious Medical, Kardium, Galvanize Therapeutics, and Solventum. Thank you for listening to the DeviceTalks Weekly podcast. ***Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

When a GI bleed strikes, the atmosphere in the procedure room changes instantly. In this episode of OlympusTalks, Olympus’ Christian Stroupe and Robert Barrett share how Olympus® technologies are designed to help physicians regain visibility and respond quickly to find the bleed and achieve hemostasis. Chapter 1: Meet the Guests Olympus’ Christian Stroupe and Robert Barrett explain their paths to medtech industry and their current roles in GI Chapter 2: Why GI Bleeding Matters The prevalence of GI bleeds and their impact on patient outcomes Why it’s one of the top reasons for endoscopy Chapter 3: The Moment Everything Changes “You just see red everywhere” – how visibility is lost and urgency takes over What it feels like when the room shifts from routine to critical Chapter 4: Finding the Bleed The challenge of pinpointing the source of the GI bleed How advanced imaging helps physicians locate and assess the bleed Chapter 5: Tools for Hemostasis Overview of Olympus’ therapeutic options: clips, powders, and thermal forceps Matching the right tool to the type of bleed Chapter 6: Reducing Repeat Patient Visits How effective hemostasis prevents rebleeds and follow-up procedures Supporting physicians in getting it right the first time Chapter 7: Hospital VS. ASC Settings Difference in procedure complexity and patient profiles Why even “routine” cases can present bleeding risks For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. This podcast has been paid for by Olympus Corporation of the Americas. ADDITIONAL RESOURCES: Discover how the EVIS X1™ Endoscopy System is elevating the standard of care and the role of RDI™ technology: https://medical.olympusamerica.com/technology/rdi Learn how EndoClot™ PHS, an advanced powder hemostat, supports physicians achieve hemostasis: https://medical.olympusamerica.com/products/endoclotphs Explore the Retentia™ HemoClip for reliable clipping and effective hemostasis during GI procedures: https://medical.olympusamerica.com/products/retentia-hemoclip *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on Yo... Chapters (00:01:18) - Meet the Guests(00:07:27) - Why GI Bleeding Matters(00:10:28) - Finding the Bleed(00:14:27) - The Moment Everything Changes(00:20:17) - Tools for Hemostasis(00:21:22) - Reducing Repeat Patient Visits(00:24:03) - Hospital VS. ASC Settings

In this week’s DeviceTalks Weekly, new Virtual Incision CEO Jim Alecxih walks us through his career, including a critical role at Intuitive Surgical, and explains why the Mira surgical robotic system convinced him to return to the industry. Olympus Ventures’ Abby Hunter-Syed keeps an eye on the broader tumult impacting MedTech. Chris Newmarker delivers the Newmarker’s Newsmakers – Insulet, Recor, Abbott, Ambu, GE Healthcare, Intuitive, Terumo and OrganOx. This episode is sponsored by DeviceTalks West. Check out the agenda and register at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Podcast Network. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:50) - Show Open/Newmarker’s Newsmakers(00:05:25) - Insulet promotes Eric Benjamin to COO role(00:07:17) - Recor Medical's Paradise renal denervation tech wins Japanese approval(00:09:51) - Two Abbott MedTech executives leaving for new roles(00:13:03) - Intuitive announces layoffs?(00:16:35) - Terumo to acquire organ preservation device maker OrganOx for $1.5B(00:20:15) - FOMO – Abby Hunter-Syed, Sr. Director, Olympus Ventures(00:29:45) - Keynote – Jim Alecxih, CEO, Virtual Incision(00:37:07) - Early reactions to a surgical robot(00:42:40) - The Xbox /The Four Ps of Value Proposition(00:45:16) - Technology = Quality care(01:08:52) - Mira is different(01:10:12) - We're not a Ferrari. We’re an F150(01:14:57) - Message to patients

In this episode of DeviceTalks Weekly, Editorial Director Tom Salemi sits down with Ken Charhut, executive chair and CEO of Foldax, to discuss how the startup’s polymer valve and robotic manufacturing process could offer a new alternative to traditional structural heart valves. David Niewolny, director of healthcare and medical business development at NVIDIA, joins as this week’s FOMO guest to share his vision for the future of technology in MedTech. Managing Editor Kayleen Brown and Salemi highlight the expanding FOMO library, preview the 2025 MedTech Nerd Tour, and celebrate a major milestone for the DeviceTalks Podcast Network. Explore our collection here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4994542/future-of-medtech-opportunities-fomo Finally, MassDevice Editor Chris Newmarker returns with his Newmarkers Newsmakers, covering Medtronic, Philips, renal denervation, NeuroOne, and Novocure. Thank you for listening to the DeviceTalks Podcast Network. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the cath lab and beyond. Dr. Korngold, an interventional cardiologist turned MedTech leader, discusses the evolution of Abbott’s vascular portfolio and how the company is integrating AI through platforms like Ultreon 2.0 to improve outcomes and procedural efficiency. The conversation covers specific applications of AI in intravascular imaging, vessel sizing, calcium detection, and future steps in stent placement guidance. He also addresses physician and hospital system perceptions of AI, why he sees it as a GPS-like tool for guiding physicians through complex procedures, and how it may soon impact pre- and post-procedural care. This episode is brought to you by Resonetics. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Want to understand the history of nitinol? Make sure to check out Eric's Veit's Nitinol Innovation: Decade-by-Decade breakdown on LinkedIn: https://www.linkedin.com/posts/eric-veit_nitinol-innovation-decade-by-decade-resonetics-activity-7358601495631552512-hm9D?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAB4aLUBXtw-TjMHSa4dOuAiKreGeEZCZM4 *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Intro + Ethan Korngold's MedTech background(00:05:14) - Abbott's Vascular Innovations and AI Integration in Healthcare(00:08:54) - Innovations in Nitinol for Medical Device Manufacturing(00:12:44) - AI Revolutionizes Vascular Procedures with Enhanced Decision-Making(00:19:47) - The Future of Nitinol in Medical and Technological Applications(00:24:04) - AI's Role in Enhancing Medical Procedures and Patient Outcomes(00:27:14) - Life-Saving Coronary Interventions and Advanced Imaging Techniques(00:29:24) - AI Revolutionizing Cath Lab Procedures and Patient Care

In this episode of the DeviceTalks Weekly Podcast, Subsense CEO and Co-Founder Tetiana Aleksandrova shares how her company is using nanoparticles to establish brain-computer interfaces with the potential to deliver powerful new therapies to the brain. In her conversation with Host Tom Salemi, she reflects on her background, the impact of the war in her native Ukraine, and her previous work on neural interfaces. Earlier in the episode, AcuityMD Co-Founder and CEO Michael Monovoukas offers a look at the future of MedTech innovation (FOMO) in a conversation with Managing Editor Kayleen Brown. This episode is brought to you by AcuityMD. Learn more at www.acuitymd.com. Also, Yvonne Bokelman, Executive Director of MedtechWOMEN, previews the upcoming MedtechVISION conference taking place Sept. 9. Register at MedtechWOMEN.org. Finally, MassDevice Editor Chris Newmarker delivers his Newmarkers Newsmakers, featuring updates on Modular Medical, SetPoint Medical, Boston Scientific, Nyxoah, and OpenAI. Thank you for listening to the DeviceTalks Weekly podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:20) - Newmarkers Newsmakers(00:06:21) - Modular Medical(00:08:18) - SetPoint Medical(00:10:14) - Boston Scientific(00:12:38) - Nyxoha(00:14:08) - OpenAI(00:16:22) - FOMO with Michael Monovoukas of AcuityMD(00:28:12) - Yvonne Bokelman, Executive Director, MedtechWOMEN(00:43:02) - Tetiana Aleksandrova, Co-Founder and CEO, Subsense(00:46:47) - Her origins/thoughts on the Russian invasion of her native Ukraine(00:52:18) - Origin of Subsense(00:56:20) - Nanoparticle technology(00:59:54) - Role of the nanoparticles

In this episode of the DeviceTalks Weekly podcast, iRhythm CEO Quentin Blackford shares his MedTech journey, the tech powering iRhythm’s arrhythmia detection, and what it takes to disrupt traditional healthcare. He talks patient engagement, predictive care, and the company’s push deeper into primary care. In this week’s FOMO, you’ll hear my interview with Zimmer Biomet CEO and President Ivan Tornos. We kick things off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers, covering Medtronic, Alcon, Staar Surgical, Inspire Medical, Edwards Lifesciences, and HistoSonics. Thanks for tuning in to DeviceTalks Weekly. *** Enjoy this episode? Follow DeviceTalks Weekly on your favorite podcast app and on YouTube.com/@DeviceTalks. Want full access to the DeviceTalks Podcast Network? Subscribe at https://devicetalks.castos.com/subscribe Chapters (00:02:04) - Newmarkers Newsmakers(00:06:10) - Medtronic(00:09:43) - Alcon(00:13:43) - Inspire Medical Systems(00:16:52) - Edwards Lifesciences(00:19:05) - HistoSonics(00:26:23) - FOMO Interview, Ivan Tornos, CEO & President, Zimmer Biomet(00:34:15) - Keynote Interview, Quentin Blackford, CEO, iRhythm(00:39:23) - Moving from CFO to CEO(00:42:43) - iRhythm overview(00:45:35) - What does profitability mean for a MedTech?(00:47:05) - Why does change take so long in healthcare?(00:51:00) - How do you engage with patients?(00:59:34) - Partnership with Lucem for predictive diagnostics(01:02:13) - Impact of Epic collaboration(01:06:57) - Importance of primary care physicians

In this episode of Ortho Innovation Talks, Terry Ross, Group President, Enovis™ Prevention & Recovery, shares how the company is reimagining orthopedic recovery through a combination of smart bracing technology and digital health platforms. Ross details how Enovis is prioritizing comfort and wearability in its bracing designs to drive better patient compliance, while also streamlining clinic operations through its MotionMD® workflow software. He also discusses MotionIQ®, a digital engagement tool designed to support patients throughout their rehab journey. With a focus on continuous improvement, Ross explains how Enovis is building connected solutions that improve patient outcomes and clinic efficiency—proving that externally applied devices can deliver powerful, tech-enabled care. This episode comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help you 'make a material difference' please visit them at https://regenity.com. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, MassDevice Editor Chris Newmarker speaks with Peter Menziuso, Johnson & Johnson company group chair for Vision, about the company’s strategy to advance vision care. J&J MedTech’s Vision business already represents one-sixth of the company’s $32 billion in annual medtech revenue, and new innovations are on the way to reach even more people with vision impairments. Recent launches include the Acuvue Oasys Max multifocal lens for astigmatism and the Tecnis Odyssey next-generation intraocular lens for cataract patients. This episode is sponsored by InterPower. Learn more at InterPower.com. Before that interview, DeviceTalks Managing Editor Kayleen Brown talks AI and diagnostics with Dennis Cheng, vice president of Cardiac Diagnostic Solutions at Boston Scientific, as part of our FOMO series. Newly minted Senior Editor Sean Whooley joins Newmarker and Host Tom Salemi to break down the week’s biggest headlines — including updates from Medtronic, Biotronik, CardioFocus, Cardiosense, and Dexcom. We’ll also review the new MassDevice Diabetes Technology Innovations Report. Thanks for listening to the DeviceTalks Weekly podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Infection preventionists are often the unsung heroes of patient safety—working behind the scenes to ensure that every procedure is as safe as possible. In this OlympusTalks episode, Jamie McGloin, Infection Prevention & Control Specialist at Olympus, and IPC consultant, Linda Dickey, bring their deep experience and unique perspectives to the forefront, offering a compelling look at the evolving role of IPs in GI endoscopy. The episode explores practical aspects of medical device reprocessing, the importance of early collaboration between healthcare providers and manufacturers, and opportunities to improve consistency across the industry. From interpreting detailed IFUs to enhancing reprocessing workflows, Jamie and Linda highlight how infection preventionists are uniquely positioned to support safe and efficient patient care. Listen now to learn how infection prevention is not just a background process—but a frontline defense in modern healthcare. For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. * This podcast has been paid for by Olympus Corporation of the Americas. The views and experiences shared are those of Dr. Linda Dickey, a paid consultant of Olympus Corporation and its affiliates. Olympus makes no representations regarding the accuracy or applicability of the content and disclaims all liability arising from its use. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Always refer to the Instructions for Use and applicable labeling for guidance, risks, and cautions. ADDITIONAL RESOURCES: See how we can focus on infection prevention, together. Visit this page for additional resources, services, and tools to help support infection prevention at your facility: https://infectionprevention.olympus.com/en-us/ For infection preventionists looking to deepen their understanding of endoscope reprocessing, APIC’s resource offers evidence-based guidance and practical tools tailored to your role: https://apic.org/the-science-behind-endoscope-reprocessing/ *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi recaps highlights from this year’s Society of Robotic Surgeons annual meeting with surgical robotics leaders Steve Bell and Joe Mullings of The Mullings Group. The conversation dives into emerging trends in telesurgery and endovascular robotics—and takes a candid look at the blind spots still facing surgical robotics executives. Before that, Salemi speaks with Emily Stelzer, Senior Manager of Solutions Engineering at Tecan, about how medical device manufacturers can “future-proof” their operations in a landscape shaped by AI, shifting global trade policies, and evolving regulatory frameworks. Thank you to our episode sponsor, Tecan. Learn more at http://partnering.tecan.com/. And, as always, Chris Newmarker kicks things off with his Newmarker’s Newsmakers—this week featuring ZimVie, Dentsply Sirona, HeartFlow, Intuitive, and Boston Scientific. Thanks for listening to the DeviceTalks Weekly Podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this week’s episode of the DeviceTalks Weekly podcast, Host Tom Salemi looks ahead to DeviceTalks 2035 with Joe Urban, global president of Zimmer Biomet’s Knee Business. Urban, a military veteran and early Auris employee, shares insights on robotics, AI, and advancing ortho innovation. (Note: This interview was recorded before ZB’s announced acquisition of Monogram Technologies.) We open with Chris Newmarker’s Newsmakers, covering Abbott, Medtronic, Zimmer Biomet, Waters, BD, and Johnson & Johnson MedTech. In this week’s Future of MedTech Opportunities (FOMO) segment, Kurt Cannon, VP of Endoscopy Marketing at Olympus, discusses how ambulatory surgery centers are reshaping MedTech. This episode is brought to you by Cortland Biomedical. To discover why Cortland Biomedical is your trusted partner in biomedical textiles, visit https://www.cortlandbiomedical.com. Thanks for listening to the DeviceTalks Weekly Podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company developing a TMS system that may be able to slow the advance of Azheimer’s. Mariash paints a hopeful picture for people - and families - fearing this dreadful disease. In our Future of MedTech Opportunities (FOMO) interview, DeviceTalks’ Emira Wininger talks with Heidi Dohse, founder and president of Tour de Heart. Dohse has used a pacemaker for nearly all of her life and brings important insights on the importance of patient design. This episode is brought to you by Interpower Corp. Go to Interpower.com for more information. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi sits down with Rachel Ellingson, chief strategy and corporate development officer at Solventum, recorded live at DeviceTalks Minnesota. Ellingson shares a rare perspective on leading medical device companies through major transitions, drawing on her experience at Zimmer Biomet during the ZimVie spinout and now at the helm of a business spun out from 3M Healthcare. She compares the two experiences and outlines what’s ahead for Solventum. In our Future of MedTech Opportunities (FOMO) segment, Kayleen Brown speaks with Athar Mirza, VP of global infusion systems at Baxter International, about Baxter’s evolving role in connected health. This episode is brought to you by Protolabs, https://www.protolabs.com. Chris Newmarker and Sean Whooley break down the latest Newmarker’s Newsmakers, featuring headlines from Science, Olympus, Johnson & Johnson, and Stryker. Plus, Whooley shares insights from the American Diabetes Association meeting in Chicago, highlighting cutting-edge diabetes tech. Thanks for tuning in to the DeviceTalks Weekly Podcast. Enjoy this podcast? Follow DeviceTalks Weekly all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this insightful episode of the OlympusTalks podcast, Host Tom Salemi of DeviceTalks explores the powerful partnership between physicians and Clinical Applications Specialists (CAS) in the field of endoscopic ultrasound (EUS). Joining the conversation are gastroenterologist Dr. Julie Yang, an early adopter of EUS, and Melissa Elliott-Walker, a seasoned CAS with Olympus. Together, they unpack the critical role CASs play in supporting physicians—from training staff and optimizing imaging to supporting procedural outcomes and patient care. Dr. Yang shares how Melissa’s expertise helped elevate her practice from the ground up, describing EUS as “the truth” in diagnostic imaging. The episode dives into how EUS has evolved from a diagnostic tool to a therapeutic powerhouse, offering minimally invasive options for patients and playing a pivotal role in diagnosis and staging. Melissa brings her decades of experience in radiology and ultrasound to life, explaining how proximity and precision make EUS the gold standard for pancreatic imaging.1 She also introduces the emerging potential of shear wave elastography in liver diagnostics. For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. * The views and experiences shared are those of Dr. Yang, a paid consultant of Olympus Corporation and its affiliates. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Potential complications that may be associated with endoscopic ultrasound include, but are not limited to, the following: sore throat, infection, bleeding, perforation, and/or tumor seeding (when EUS-FNA or FNB is performed). Salom, F., & Prat, F. (2022). Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer. World journal of gastrointestinal endoscopy, 14(1), 35–48. https://doi.org/10.4253/wjge.v14.i1.35 Accessed July 2025. ADDITIONAL RESOURCE: Connect with your local CAS. They are ready to support your EUS practice and help you enhance patient care. For more information, visit: info.olympusamericamarketing.com/eus-cas *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Paul LaViolette, president and CEO of Pulse Biosciences. LaViolette takes us back to the early days of the medical device industry and shares how close collaboration with interventionalists helped shape today’s MedTech landscape. We dive into one of the biggest deals in MedTech history — Boston Scientific’s acquisition of Guidant — and why it was crucial for the company’s survival despite its rocky road. LaViolette also explains why investing in MedTech has never been more challenging and what drew him to lead Pulse Biosciences, a company pushing the boundaries of energy-based devices. Before that, we’re proud to launch our new Future of MedTech Opportunities (FOMO) series, sponsored by Protolabs, https://www.protolabs.com/. In this installment, we speak with Anthony Jarc, vice president of digital and machine learning at Intuitive. And as always, Chris Newmarker of Newmarker’s Newsmakers rounds up the biggest headlines, covering SS Innovations, Medtronic, Virtual Incision, and highlights from the American Diabetes Association’s annual meeting. Thanks for tuning in to DeviceTalks Weekly. Make sure to subscribe to the DeviceTalks Podcast Network so you never miss an episode: https://devicetalks.castos.com/subscribe

In this episode of Ortho Innovation Talks, Marc Mackey, senior vice president and general manager of Enabling Technologies at Enovis, breaks down how his team is building a next-generation platform that prioritizes precision, efficiency, and value. Mackey explains how augmented reality and AI are making orthopedic surgeries more accurate, efficient, and accessible — especially in outpatient environments like ASCs. He details the evolution of Enovis’ AR-based navigation platform, ARVIS, from early prototypes to its current compact, cost-effective design that eliminates the need for bulky hardware. As adoption grows, Mackey highlights how surgeons are leveraging ARVIS for soft tissue balancing, gap assessment, and patient-specific alignment, while AI streamlines surgical planning and imaging segmentation. This conversation comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help support you, visit them at https://regenity.com. Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe.

In this podcast episode, MassDevice Editor Chris Newmarker sits down with Christian Mazzi, CEO of Corcym — formerly LivaNova’s surgical heart valve business — about how it has transformed since it became an independent company under Gyrus Capital in 2021. Next up is an effort to expand innovation beyond Corcym’s core heart valve portfolio to areas such as heart failure treatment. Mazzi, though, still has a lot to say about surgical heart valve replacement when speaking with MassDevice Editor in Chief Chris Newmarker. Surgical heart valve procedures are shifting toward being more laparoscopic, and surgical robotics applications are on the horizon. Even as transcatheter heart valves generate a lot of buzz in medtech, surgical heart valve innovation is getting exciting, too. Like the Arthurian heroes that Corcym names its products after, Mazzi and his company are on a quest. But first Host Tom Salemi, DeviceTalks Managing Editor Kayleen Brown and Newmarker share their highlights of the wildly successful DeviceTalks Minnesota that took place on June 11. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, we share Zimmer Biomet CEO Ivan Tornos’ stellar visit to DeviceTalks Boston where he laid out the orthopedics’ company’s plan to be the boldest MedTech in the world (and spilled some tea about how the company paired up with Arnold Schwarzenegger.) Thank you to Protolabs for sponsoring this episode. Visit Protolabs.com for more information on how Protolabs works with medical device companies. Tom Salemi and Chris Newmaker are joined by Heather Hudnut Page for this week’s Newmarker’s Newsmakers. The trio preview DeviceTalks Minnesota and highlight the region’s newsmakers including Solventum, Medtronic, Boston Scientific and Inspire Medical Systems. Check out the agenda for the June 11 meeting at Minnesota.DeviceTalks.com. Join us on June 12 for DeviceTalks Thursdays at Target Field! Buy your ticket to see the Twins game here. https://www.gofevo.com/event/DeviceTalks Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

In this episode of AbbottTalks, we dive into the surprising origins of neuromodulation, kicking off with a shocker (literally)—treating headaches with electric fish. Neuromodulation expert Yagna Pathak, PhD, Medical Science Manager of Medical Affairs at Abbott’s Neuromodulation business, explains how therapies like spinal cord and deep brain stimulation have evolved, detailing their impact on chronic pain and movement disorders. She outlines how Abbott is expanding neuromodulation applications through research in treatment-resistant depression and by integrating AI, wearables, and digital health tools. Pathak also shares how connected care technologies—including the Neurosphere Virtual Clinic and the new Neurosphere Digital Health app—are improving patient outcomes. These platforms enhance access, enable timely interventions, and provide valuable educational resources for patients and providers. Thank you to Cirtec Medical for sponsoring this episode of AbbottTalks. For more information on how Cirtec Medical works with medical device companies, visit https://www.cirtecmed.com/, and to learn more about Cirtec Medica’s Simplifi Platform, click: https://www.devicetalks.com/wp-content/uploads/2025/06/simpifi-overview_litsheet.pdf Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi speaks with Cecilia Soriano, global president of Infusion Therapies and Technologies at Baxter. Soriano details how the company responded after Hurricane Helene severely damaged its North Carolina facility last fall. With floodwaters halting operations and disrupting supplies—especially IV bags—Baxter had to make bold, fast decisions to get back online. Soriano shares key lessons in crisis response and supply chain resiliency. This episode is sponsored by Aptyx. Go to Aptyx.com to find more information on how Aptyx works with medical device companies. If you want to see the video reference in the talk, go to https://www.youtube.com/watch?v=j091JNt-SLc. We’ll start the episode with this week’s Newsmarker’s Newsmakers. Managing Editor Kayleen Brown joins Salemi and MassDevice Editor Chris Newmarker to highlight the week’s biggest news from Zimmer Biomet, Hologic, Abbott, Boston Scientific, and Medtronic. We also pinpoint our favorite parts of the agenda for DeviceTalks Minnesota, which is happening June 11 at the McNamara Alumni Center. Register to attend at Minnesota.DeviceTalks.com! Use the code mentioned in the podcast to save 25%.

In this moving episode of the OlympusTalks podcast, host Tom Salemi of DeviceTalks explores the topic of pancreatic cancer. The episode features Rich Burde, Director of Marketing in EUS Solutions at Olympus, alongside special guests, pancreatic cancer survivor, Rob Schasteen and his daughter Brooke Schasteen-Smith. The conversation expands on Olympus’ focus on pancreatic cancer, its prevalence and Olympus’ mission to support physicians in the critical role of diagnosis and treatment. Rob shares his personal battle with stage four pancreatic cancer, recounting his initial diagnosis and the invaluable support from his family, particularly Brooke, who relocated to Pennsylvania to care for him. Brooke, actively involved with the Pancreatic Cancer Action Network (PanCAN), highlights the organization's pivotal role in offering vital resources, case management, and education for families affected by pancreatic cancer. Tune in for more on the importance of seeking multiple medical opinions, maintaining hope and a positive attitude, and the significant support provided by PanCAN. Learn more about Olympus’ partnership with PanCAN and the resources and support available for families in their fight against pancreatic cancer. For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. ADDITIONAL RESOURCES: To learn more about pancreatic cancer and for resources on early screening, visit https://www.pancreaticcancerscreening.com/. To explore Olympus’ EUS solutions, visit https://medical.olympusamerica.com/procedure/endoscopic-ultrasound-eus. For essential resources and more information on patient services from the Pancreatic Cancer Action Network, visit https://pancan.org/.

In this episode, Host Tom Salemi interviews Steve Mapa, a former MedTech leader who is now president and executive director of MedTechVets. In this conversation, we learn how Mapa found a path to the medical device industry a decade after leaving the army. He explains how MedTech fills the need to serve so many veterans still hold onto, and how MedTechVets is helping active service members and veterans transition into the MedTech industry. This episode is sponsored by DeviceTalks Minnesota. To join us in Minneapolis on June 11 go to Minnesota.DeviceTalks.com to register. Use the code DTWEEKLY25. But we’ll start this episode off with our Newmarker’s Newsmakers - Salemi, MassDevice Editor Chris Newmarker and Associate Editor Sean Whooley kick around the news about AdvaMed, Dexcom, Johnson & Johnson MedTech, Intuitive, Medtronic, and, of course, Juicy Lucys and the Dinky Dome. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi learns how ArteDrone, hopes to empower more interventionalists to deliver life-saving, stroke-clearing treatments. The company is combining digital twin navigation with a magnet-powered catheter to make clot removal more of a trade than an art. CEO Liane Teplitsky returns to DeviceTalks Weekly in her new role as CEO of the early-stage, VC-backed startup. This episode is sponsored by DeviceTalks Minnesota. To review the agenda, go to Minnesota.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies. Overseeing product launches in over 100 countries, he discusses the deep need for pain relief and other benefits of neuromodulation, and the challenges presented by EMEA’s unique health care markets. This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to register. Use the discount code mentioned in the episode. But we’ll start off the episode with MassDevice Editor Chris Newmarker’s #NewmarkersNewsmakers including Cardinal Health, AdvaMed, Zimmer Biomet, EndoGenex, HistoSonics, and orthopedic companies. Go to MassDevice.com for our medical device coverage. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, we review a few of the highlights of this week’s DeviceTalks Boston conference, a rip-roaring successful event! DeviceTalks Tom Salemi and Kayleen Brown sit down with MassDevice Editor Chris Newmarker and Joe Mullings of The Mullings Group to review a few of the sessions. But the conversation took a turn into the personal, centering around how to use tools - including language, social media and networks - to tell stories and maintain connections. Finally, the group unpacks discussion with Ivan Tornos, CEO of Zimmer Biomet, the Women in MedTech Breakfast, and what we can do to make MedTech more attractive to the next generation. If you attended DeviceTalks Boston please fill out the feedback survey sent out on Friday! Help us make next year’s event even better. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this debut episode of OlympusTalks, Host Tom Salemi welcomes Olympus Corporation of the Americas’ Vice President of Endoscopy Marketing Kurt Cannon, and colorectal cancer survivor and advocate Brooks Bell for a candid discussion on the importance of early screening. They explore Olympus’ role in advancing endoscopic technology and how it contributes to early detection and prevention of colon cancer. Bell shares her personal experience with early-onset colorectal cancer, highlighting the urgent need to shift cultural perceptions around colonoscopies. She discusses her work through Worldclass Clothing, a nonprofit aimed at removing barriers to screening. Cannon elaborates on Olympus' commitment to improving adenoma detection rates and sheds light on how their latest innovation, the EVIS X1™ endoscopy system, is designed to support this mission. Colorectal cancer is rising in younger adults—but early screening can make all the difference. Tune in to hear how innovation, advocacy, and awareness are coming together to tackle colorectal cancer. For more episodes by OlympusTalks, please visit http://olympusamerica.com/podcasts. *Brooks Bell is a paid endorser of Olympus Corporation, its subsidiaries, and/or its affiliates. **The content of this podcast was paid for by Olympus. ADDITIONAL RESOURCES: • To learn more about the EVIS X1™ Endoscopy System, visit https://medical.olympusamerica.com/products/evis-x1. • For resources on colorectal cancer screening and to read patient stories, visit https://www.colonoscopytoday.com/. To follow OlympusTalks on your favorite podcast player and YouTube, please visit: https://olympustalks.castos.com/subscribe Thank you for listening to the OlympusTalks podcast!

In this episode of the DeviceTalks Weekly Podcast, we’ll get a small taste of what’s to come at DeviceTalks Boston. Host Tom Salemi interviews Paul Grand of MedTech Innovator, Holly Scott of The Mullings Group, and Peter Stebbins of Satio about the state of startups in Boston and the hot topics in MedTech. Managing Editor Kayleen Brown warms up for her fireside chat with Charisse Sparks, MD, former chief medical officer at Inspire Medical Systems. Dr. Sparks will be the opening keynote interview on Day 2 of DeviceTalks Boston. Don’t miss it! Register at Boston.DeviceTalks.com. Use the code mentioned inside to save 25%. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders. Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next. Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIR™ DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2i™ (implant-to-implant) technology. The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives. Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/ Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this episode of the DeviceTalks Weekly Podcast, Tom Salemi talks with seasoned MedTech executive Daniel Levangie about the blood-brain barrier-breaking technology being developed by CereVasc. The company has developed a less invasive way of treating patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults. But the company’s tech gives physicians access to the brain, creating a potentially huge opportunity for future applications. Just prior to the keynote interview, Tom talks with orthopedic surgeon and OrthoShow podcast host Scott Sigman, MD, about the Future of Orthopedics, a conversation they’ll resume at the start of DeviceTalks Boston. Go to Boston.DeviceTalks.com to register to attend the April 30-May 1 conference. Use the code mentioned frequently in the podcast to save 25%. But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers - Abbott, Boston Scientific, Edwards Lifesciences, EBR Systems, and Johnson & Johnson MedTech. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability. He details how the company strategically leverages dual sourcing, inventory buffering, and global distribution flexibility to maintain operations, even when borders close or suppliers face challenges. He also unpacks the need for automation and digital integration, explains how Edwards connects employees to patient outcomes to instill purpose, and reveals why fostering innovation readiness is central to their long-term strategy. Thank you to Daikin America for sponsoring this episode of Structural Heart Talks. To learn more about Daikin America’s products for your medical application visit https://daikin-america.com. Wait, there’s more! Want to learn more about Daikin America’s new Co-Extrusion technology? Click here for a high resolution image with more detail. Thank you for listening to the Structural Heart Talks podcast. Subscribe to Structural Heart Talks or the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks on YouTube Podcasts to ensure you never miss an episode.

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO. CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care. Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech. Finally, MassDevice Editor Chris Newmarker and Tom talk about the impact President Trump’s tariff tactics are having on the MedTech industry. This episode is brought to you by DeviceTalks Boston, April 30 - May 1. Boston.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, Dr. Nadine Hashash-Haram discusses her journey as a surgeon and the founder of Proxime, a digital health platform that enhances surgical procedures through technology. She shares insights on the evolution of Proxime, its impact on healthcare systems, and the importance of collaboration with medical device companies. Before that interview, Jonathan Norris, managing director at HSBC Innovation Banking, reviews first quarter MedTech VC investment numbers. There’s good news, bad news and a lot of in-between as privately held medical device companies. This episode is sponsored by DeviceTalks Minnesota. Find the discount code inside this podcast. Go to Minnesota.DeviceTalks.com to register for the June 11 event. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry - Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute. Cleeland will share insights on leading a MedTech start-up and shares some concerns he has for the industry at large. The Fogarty Institute is also promoting the Thomas J. Fogarty prize for medical innovation, a $100,000 prize for one person or a small group of people who have broken new ground in the industry. Go to this article at Medical Design & Outsourcing for more information. https://www.medicaldesignandoutsourcing.com/mike-mussallem-tom-fogarty-prize-medtech-innovation/ Before that conversation, Host Tom Salemi and Holly Scott, managing partner at The Mullings Group, interviewed Cecilia Soriano, global president of Infusion Therapies and Technologies, at Baxter. We’ll preview Soriano’s interview at DeviceTalks Boston where she’ll talk about Baxter’s recovery from Hurricane Helene. But we’ll start the episode off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers including the FDA, HHS, Alcon, Abbott and Johnson & Johnson MedTech. Thanks for listening to this episode of the DeviceTalks Weekly podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes. Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics. Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations. Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely. But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers. But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies. You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/ Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In the kickoff episode of Season 2 of Ortho Innovation Talks, Louie Vogt, Group President of Reconstructive at Enovis, takes us inside the company’s strategic growth in orthopedics. Vogt shares how Enovis has transformed into a major player in the reconstructive space through key acquisitions and bold bets on innovative implant designs. He discusses the evolution of knee implants, highlighting Enovis’ pioneering work with kinematically driven bearings and the dual pivot knee concept. Vogt also touches on the growing role of robotics and enabling technologies in orthopedic surgery, emphasizing how these advancements are changing the surgeon experience and patient outcomes. Beyond knees, Vogt explores Enovis’ expansion into foot and ankle reconstruction—a rapidly growing market—and how the company is leveraging M&A and innovation to carve out a competitive edge. As Enovis looks ahead to 2025, Vogt teases major product launches in shoulders, hips, and extremities, signaling another big year for the company. This conversation comes to you courtesy of our sponsor, Paragon Medical. To learn more about how Paragon Medical can help you bring your device to market faster, visit them at www.paragonmedical.com. Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!

In this episode of the DeviceTalks Weekly Podcast, it’s a DeviceTalks Team Up. Editorial Director Tom Salemi and Managing Editor Kayleen Brown interview Doug Evans, CEO and President of Lungpacer Medical. Evans shares the tragic reason he vowed to start a company that would help wean patients off ventilators. We’ll hear his success story in the podcast, but join us at DeviceTalks Boston to hear the story behind the AeroPace technologies as Evans will be joined by Lungpacer COO Viral Thakkar and Mike Longo, vice president of product development. Register to attend DeviceTalks Boston at Boston.DeviceTalks.com. If you missed our early bird rate use the code mentioned in the podcast on March 1 and 2. Before the DeepDive conversation, we’ll have Mass Device Honcho Chris Newmarker’s Newsmakers - Medtronic, Solventum, FDA layoffs, Boston Scientific, and Teleflex. Jim Hammerand, managing editor of Medical Design & Outsourcing, opens with an overview of the magazine’s current Min-Vasive issue. You can find all the articles mentioned at medicaldesignandoutsourcing.com. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker sits down with Wayne Paterson, CEO of Anteris Technologies, a unique start-up that’s approaching the complicated and competitive TAVR market. Chris Newsmaker and Host Tom Salemi also discuss this week’s Newmarker’s Newsmakers including Medtronic, Boston Scientific, Johnson & Johnson MedTech, NeuroPace and the FDA. This episode was sponsored by DeviceTalks Minnesota. Register to attend the June 11 event at Minnesota.DeviceTalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalks Weekly Podcast, Meghan Scanlon, SVP and president of urology at Boston Scientific, updates us on the integration of its powerhouse neurostim acquisition – Axonics. Scanlon also offers great insights on what makes the urology business such a powerful specialty for physicians and medical device executives. Go here to listen to Scanlon’s first visit with DeviceTalks Weekly. https://www.devicetalks.com/boston-scientific-and-zenflow-are-bringing-critical-new-tools-to-help-urologists-treat-patients/ DeviceTalks Managing Editor Kayleen Brown sits down with Kevin Dempsey, senior director of business development at Tecan, about the opportunities in neuromodulation. Tecan is the sponsor of this episode. To learn more about Tecan visit, https://partnering.tecan.com/ MassDevice Editor Chris Newmarker brings a basket of Newmarker’s Newsmakers including Inspire Medical, Kestra Medical, MGB Layoffs, Medtronic and Johnson & Johnson. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Dr. Maria Artunduaga, the founder and CEO of Samay, a startup that’s using acoustic energy to get a clearer picture of the lung’s performance. Family tragedy and professional frustration set Dr. Artunduaga on a course that won MedTech Innovator’s Grand Prize. She has the giant check to prove it. This episode was sponsored by DeviceTalks Boston. You can register at Boston.DeviceTalks.com. Rachel Robinson, COO of MassMEDIC, joins us on the Newmarker’s Newsmakers. Before we hit the news of the week, Robinson gave a preview of the upcoming MassMEDIC’s Symposium & Gala on March 6. Go to MassMEDIC.com for more information. MassDevice Executive Editor Chris Newmaker then delivers news on - Boston Scientific, ResMed, Globus Medical, BD and Baxter. Hilarity ensues. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In 2024, only months before the world lost Dr. Nick Hopkins, Host John Murray, sat down with Dr. Hopkins to discuss his innovative treatments in stroke care, the necessity of collaboration and partnerships to advance research and clinical care, and the importance of mentorship and training the next generation of neurosurgeons. In this special memorial episode, we hear Dr. Hopkins reflect on “not doing everything by the book, but looking around to ask: is there a better way than what’s in the book?” He shares his philosophy on embracing and learning from mistakes that have fueled advancements in neurovascular methodologies and inspired a culture of openness in the medical community. A champion of mentorship, Dr. Hopkins has acted as a guiding force for numerous professionals, shaping the future of neurovascular surgery. The episode also delves into the ethical and moral compass that underlies Dr. Hopkins’ work, reaffirming the profound humanity that anchors his approach to both his profession and personal life. To honor the depth of Dr. Hopkins’ legacy, we hear directly from many of his mentees and fellows, including Dr. Adnan Siddiqui, Dr. Ricardo Hanel, Dr. Chuck Kerber, Dr. J. Mocco, Dr. Qureshi, Dr. Raphael Rodriguez, Dr. Demetrius Lopes, and Dr. Ajay Wakhlo on the personal and professional impact he has had on their lives and careers. Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com. Special thanks to Dr. Hopkins’s mentees and fellows who shared their stories and to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, and Dr. Elad Levy. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode. Thank you for supporting the Neuro Innovation Talks podcast!

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Highridge CEO Rebecca Whitney and Executive Chairman Eric Major about the swirling spinal market. Whitney and Major share what makes the spine industry different from other MedTech sectors and why they believe Highridge is uniquely positioned to grab a large piece of the market. The episode is sponsored by DeviceTalks Boston. Register to attend at Boston.DeviceTalks.com. DeviceTalks listeners can find our first interview with the Highridge team here. https://www.devicetalks.com/hear-highridge-medicals-plans-to-scale-the-spine-market-a-preview-of-the-medtechvision-conference/ MassDevice Editor Chris Newmarker returns with the Newmarker’s Newsmakers sharing stories about Stereotaxis, the FDA, Philips, Zimmer Biomet, and Stryker. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

In this episode of the DeviceTalk Weekly podcast, Host Tom Salemi talks with MedTech legend Daniel Hawkins, a serial entrepreneur who has a hand in many industry success stories. He was employee number six at Intuitive before setting out on a path of innovation, developing the technologies around companies like Shockwave Medical. More recently, Hawkins was CEO of Avail Medsystems, the presumed leader of the pack of companies trying to redefine OR communications, but that company shuttered last year when it couldn’t raise additional capital. Today, Hawkins is leading Vista.ai, which is selling an AI-enabled package that makes it much easier for MRI technologists to capture meaningful images of the heart. Hawkins sees Vista.ai as improving patient care while also helping imaging centers address the crushing shortfall of experts. This episode is sponsored by DeviceTalks Boston. Register to attend our April 30-May 1 event of the year at Boston.Devicetalks.com. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss out on a future episode.